Literature DB >> 8327418

A randomized trial of the impact of risk assessment and feedback on participation in mammography screening.

S J Curry1, S H Taplin, C Anderman, W E Barlow, C McBride.   

Abstract

BACKGROUND: Although rates of mammography screening among women in the general population have been increasing they still fall short of national goals. This study evaluated the effects on rates of participation in mammography screening of obtaining risk factor information and providing general or personalized risk information through direct mailed correspondence.
METHODS: Women enrollees in a health maintenance organization (N = 2,076), age 50 and above, were randomized to one of the following four groups: (a) no risk factor questionnaire + generic invitation, (b) no risk factor questionnaire + general risk invitation, (c) risk factor questionnaire + general risk invitation, and (d) risk factor questionnaire + personal risk invitation. Computerized visit records were monitored for 12 months following a mailed invitation to assess whether a mammogram had been obtained.
RESULTS: Overall participation was 37.5% and the rate of participation did not differ significantly across groups (P = 0.26). Participation was related to age (P < 0.02), with rates highest for women ages 60-69 years (42.7%) compared with those for women ages 50-59 (35.5%) and those age 70+ (33.7%). Among women with a family history of breast cancer, the personalized risk invitation was associated with significantly higher participation compared with general risk invitation (66.7 versus 42.9%, respectively; P < 0.003).
CONCLUSIONS: Women with a family history of breast cancer are more likely to obtain a mammogram if that fact is reinforced as a risk factor. Research on environmental barriers to mammography screening may suggest alternative strategies for increasing participation.

Entities:  

Mesh:

Year:  1993        PMID: 8327418     DOI: 10.1006/pmed.1993.1029

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

Review 1.  Effects of communicating individual risks in screening programmes: Cochrane systematic review.

Authors:  Adrian Edwards; Silvana Unigwe; Glyn Elwyn; Kerenza Hood
Journal:  BMJ       Date:  2003-09-27

2.  Effectiveness of a worksite intervention to reduce an occupational exposure: the Minnesota wood dust study.

Authors:  DeAnn Lazovich; David L Parker; Lisa M Brosseau; F Thomas Milton; Siobhan K Dugan; Wei Pan; Lynette Hock
Journal:  Am J Public Health       Date:  2002-09       Impact factor: 9.308

3.  Screening mammography and constructs from the transtheoretical model: Associations using two definitions of the stages-of-adoption.

Authors:  W Rakowski; B Ehrich; C E Dubé; D N Pearlman; M G Goldstein; K K Peterson; B K Rimer; H Woolverton
Journal:  Ann Behav Med       Date:  1996-06

4.  How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets.

Authors:  E K Slaytor; J E Ward
Journal:  BMJ       Date:  1998-07-25

5.  The effects of mailed reminders and tailored messages on mammography screening.

Authors:  Kevin D McCaul; Kimberly S Wold
Journal:  J Community Health       Date:  2002-06

Review 6.  Personalised risk communication for informed decision making about taking screening tests.

Authors:  Adrian G K Edwards; Gurudutt Naik; Harry Ahmed; Glyn J Elwyn; Timothy Pickles; Kerry Hood; Rebecca Playle
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  Increasing intentions to use mental health services among university students. Results of a pilot randomized controlled trial within the World Health Organization's World Mental Health International College Student Initiative.

Authors:  David Daniel Ebert; Marvin Franke; Fanny Kählke; Ann-Marie Küchler; Ronny Bruffaerts; Philippe Mortier; Eirini Karyotaki; Jordi Alonso; Pim Cuijpers; Matthias Berking; Randy P Auerbach; Ronald C Kessler; Harald Baumeister
Journal:  Int J Methods Psychiatr Res       Date:  2018-11-20       Impact factor: 4.035

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.